Madison El-Saadi

Stock Analyst at B. Riley Securities

(4.45)
# 458
Out of 5,182 analysts
16
Total ratings
68.75%
Success rate
21.44%
Average return

Stocks Rated by Madison El-Saadi

COMPASS Pathways
Apr 24, 2026
Initiates: Buy
Price Target: $17
Current: $8.44
Upside: +101.42%
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26$31
Current: $24.16
Upside: +28.31%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50$63
Current: $33.98
Upside: +85.40%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61$101
Current: $70.13
Upside: +44.02%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11$14
Current: $6.84
Upside: +104.68%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19$37
Current: $7.52
Upside: +392.02%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $185.00
Upside: -3.24%